Navigation Links
Misconceptions about HPV vaccine explored in special issue of scientific journal
Date:10/19/2013

INDIANAPOLIS -- Suspicions about sexual promiscuity and vaccine safety are explored in an article in the November issue of the journal Preventive Medicine, which dedicates a section of that issue to research concerning the human papillomavirus.

"Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation" is a review of journal articles and other medical and social science literature exploring beliefs held by the general public that have an impact on HPV vaccination acceptance.

Human papillomavirus is the primary cause of cervical cancer, with 12,000 new cases diagnosed each year, according to the Centers for Disease Control and Prevention. Cervical cancer causes about 4,000 deaths in women each year in the United States and is a leading cause of cancer death in developing countries. According to the CDC, about 15,000 HPV-associated cancers -- including cervical, anal, vaginal, vulvar and oropharyngeal -- in U.S. women each year may be prevented by vaccines.

Two HPV vaccines are licensed by the FDA and recommended by the CDC. These vaccines are Cervarix, made by GlaxoSmithKline, and Gardasil, made by Merck.

The authors chose topics that they consider timely and important as they explored reasons for a lower-than-anticipated rate of HPV vaccination in adolescents and young adults ages 11 to 26.

Among those topics critically examined were "fears about risk compensation or sexual disinhibition after vaccination, concerns about vaccine safety, inadequate vaccination recommendations by health care providers, and distrust due to the perceived 'newness,' as well as the perceived 'stigma' of HPV vaccines," said first author Gregory D. Zimet, Ph.D., a professor of pediatrics in the Section of Adolescent Medicine at the Indiana University School of Medicine, co-director of the Indiana University-Purdue University Indianapolis Center for HPV Research and a member of the Indiana University Melvin and Bren Simon Cancer Center.

One of the presumed concerns about the HPV vaccine is that it will result in "sexual risk compensation" -- the initiation of sexual activity at a younger age or reduction of self-protection use.

Dr. Zimet said that according to several published studies, a reduction in safe-sex behaviors and initiation of sexual behavior have been explored in numerous media stories, but it is not identified by most parents as a reason for not vaccinating their daughters.

"A study published in 2012 of 13- to 21-year-old females who had just received their first dose of vaccine found that a large majority of participants recognized the need for ongoing safer sexual behaviors post-vaccination," Dr. Zimet said. "A longitudinal study in the United Kingdom surveyed 16- and 17-year-old girls before and after HPV vaccine was offered and found that participants who received vaccine were not more likely to have initiated sexual intercourse at the time of the follow-up survey. Furthermore, among those who were sexually active, vaccination status was not predictive of frequency of condom use."

"All the studies show there is no evidence of initiation of sexual behavior, use of condoms or prevalence of sexually transmitted infections between the vaccinated and the non-vaccinated groups reported in various studies in 2012," Dr. Zimet said.

Vaccine safety is sited as a concern by some parents because of the newness of the HPV vaccine. However, Dr. Zimet said the numerous large-scale studies on HPV vaccine safety have been published showing little or no evidence of severe side effects associated with the vaccine. This data is tracked nationally by the Vaccine Adverse Event Reporting System.

Dr. Zimet said the HPV vaccine has been available in the U.S. and Canada since 2006 and in Australia since 2007, so it should no longer be viewed as a new vaccine. "Making the choice to not vaccinate is less safe than choosing to vaccinate," Dr. Zimet said. "Not vaccinating is a risky decision."

Lack of clear health care provider recommendations for the HPV vaccine has been identified as one principal reason for the relatively low vaccination rates in the United States. Although health care providers generally support vaccination for HPV, factors such as time constraints, patient age, availability of health care coverage and potential discussions about sexuality with adolescent patients are reasons cited for not promoting vaccination.

The article suggests that offering communication strategies to health care providers could eliminate some of the problem. Another approach is to establish school-based HPV vaccination, which has been shown to be successful in Australia, the United Kingdom and Canada, where HPV vaccine completion rates are high.

"Accumulating evidence suggests that many of the social/behavioral concerns associated with HPV vaccine that have sparked resistance among patients and providers and have been the focus of media reports have little or no basis in reality," the article concludes.

What is the author's take-home message for parents and health care providers? "It is important to remember that risk compensation -- real or imagined -- is not a rationale for withholding vaccine. Instead, it is a rationale for ensuring adequate education both pre- and post-vaccination."


'/>"/>

Contact: Mary Hardin
mhardin@iu.edu
317-274-5456
Indiana University
Source:Eurekalert  

Related medicine news :

1. New findings by GW researcher break tanning misconceptions: There is no such thing as a safe tan
2. ANY LAB TEST NOW®’s Terri McCulloch Details the Misconceptions about Drug and DNA Testing to Legal Investigators
3. Upcoming Webinar by RetirementHomes.com: Senior Living Marketing Myths, Misconceptions, and Money Pits to Avoid at Any Cost
4. Believing Myths and Misconceptions About Heart Disease May Increase Heart Attack Risk, from the June 2013 Harvard Heart Letter
5. What can Hollywood teach us about our planet?
6. Stress about wifes breast cancer can harm a mans health
7. Concerns about MRSA for expectant mothers may be unfounded
8. Adjusting Your Attitude About Chronic Pain May Help You Sleep
9. Moffitt researchers find adolescents with cancer concerned about their future reproductive health
10. About 1 baby born each hour addicted to opiate drugs in U.S., U-M study shows
11. People Love Talking About Themselves, Brain Scans Show
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Misconceptions about HPV vaccine explored in special issue of scientific journal
(Date:1/23/2017)... ... January 23, 2017 , ... A Northwestern Pennsylvania ... domain address. Alpine Springs Rehabilitation & Recovery Center’s new website can be found ... along with its redesigned and retooled website. The treatment center has also revamped ...
(Date:1/23/2017)... ... 2017 , ... Ultimate Medical Academy today announced the keynote ... March 23-25, 2017 in Tampa, and reminded educators and education leaders to submit ... Dr. Michelle R. Weise, executive director of the Sandbox Collaborative, the R&D arm ...
(Date:1/23/2017)... ... ... and plastic balance boards have been around since at least the 1950s and are a ... first and only balance board to use a patent-pending design featuring high-pressure inflation technology and ... as well as skill-level adjustable for all ages and abilities. The board can be ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the premiere organization in North America for the scientific development, healthcare training and ... Annual Scientific Session, and its 2017 AAT Member Certification Qualification Courses for Technicians, ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... However, choosing the right method is paramount to success. Selecting an inappropriate measurement ... situations where multiple persons use the same equipment. Rare or expensive substances are ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... New York , January 23, 2017 ... Non-Invasive Prenatal Testing Market was valued at US$0.53 bn in ... expanding at a strong 17.50% CAGR between 2014 and 2022. The ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... Non-invasive ...
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is ... incidence of depression worldwide is anticipated to drive the market growth in the ... demand for antidepressants in the recent years. Continue ... ... ...
(Date:1/23/2017)... SAN DIEGO , 23. Januar 2017  ResMed ... China ) und 3B Medical ( Winter ... sich auf eine Vereinbarung über die Beilegung aller globalen ... ist der Verkauf ihrer bestehenden Produkte im ... eine einmalige Zahlung an 3B leisten, um das in ...
Breaking Medicine Technology: